Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron May 21, 2021 7:23pm

117 Views

Post# 33252822

todays trades

House Positions for C:VXL from 20210521 to 20210521

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
85 Scotia	36,750	3,491	0.095	0			36,750	-3,491
19 Desjardins	25,789	2,459	0.095	736	69	0.094	25,053	-2,390
1 Anonymous	79,600	7,520	0.094	59,944	5,757	0.096	19,656	-1,763
14 ITG	3,000	285	0.095	0			3,000	-285
2 RBC	7,444	714	0.096	5,350	491	0.092	2,094	-223
68 Leede	3,464	323	0.093	2,001	194	0.097	1,463	-129
39 Merrill Lynch	0			590	53	0.09	-590	53
212 Virtu	2,000	190	0.095	2,789	264	0.095	-789	74
33 Canaccord	0			2,000	200	0.10	-2,000	200
79 CIBC	4,123	402	0.098	7,500	712	0.095	-3,377	310
9 BMO Nesbitt	0			5,000	450	0.09	-5,000	450
7 TD Sec	28,233	2,720	0.096	62,984	5,971	0.095	-34,751	3,251
80 National Bank	29,067	2,769	0.095	70,576	6,713	0.095	-41,509	3,944
TOTAL	219,470	20,873	0.095	219,470	20,874	0.095	0	1